Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke

NCT05035953 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic

Interventions

DRUG: Edaravone Dexborneol
DRUG: Placebo

Sponsor

Huashan Hospital

Collaborators

[object Object]